| Item type |
デフォルトアイテムタイプ_（フル）(1) |
| 公開日 |
2023-11-22 |
| タイトル |
|
|
タイトル |
Utility of CHA2DS2-VASc Score to Predict 1 Mid-Term Clinical Outcomes in Hemodialysis Patients |
|
言語 |
en |
| 作成者 |
Okubo, Aiko
Doi, Toshiki
Morii, Kenichi
Nishizawa, Yoshiko
Yamashita, Kazuomi
Shigemoto, Kenichiro
Mizuiri, Sonoo
Usui, Koji
Arita, Michiko
Naito, Takayuki
Masaki, Takao
|
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 権利情報 |
|
|
言語 |
en |
|
権利情報 |
© 2022 S. Karger AG, Basel. The final, published version of this article is available at https://karger.com/?doi=10.1159/000522225. |
| 権利情報 |
|
|
言語 |
en |
|
権利情報 |
This is not the published version. Please cite only the published version. |
| 権利情報 |
|
|
言語 |
ja |
|
権利情報 |
この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。 |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
CHA2DS2-VASc score |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
Mortality |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
Hemodialysis |
| 内容記述 |
|
|
内容記述 |
Background. The CHA2DS2-VASc score has been widely used to predict stroke in patients with atrial fibrillation (AF). Recently, it was reported that the CHA2DS2-VASc score helps predict cardiovascular disease (CVD) or all-cause mortality in patients with or without AF. However, few reports have examined the association between this score and mortality in hemodialysis patients. Methods. We analyzed 557 consecutive patients who initiated hemodialysis at our facilities between February 2005 and October 2017. The CHA2DS2-VASc score was calculated at the time of initiation of hemodialysis. Patients were then categorized into three groups according to their CHA2DS2-VASc scores: 0–1 (low), 2–3 (intermediate), and 4–9 (high). Multivariate Cox proportional hazards analysis was used to assess independent risk factors for 3-year all-cause mortality. Results. During the 3-year follow-up period, 153 (27.5%) patients died (cardiovascular death: n=88). According to multivariate analysis, serum albumin (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.43–0.85, P=0.003), creatinine (HR 0.91, 95% CI 0.84–0.99, P=0.049), and CHA2DS2-VASc score (HR 1.33, 95% CI 1.20–1.46, P<0.001) were associated with 3-year all-cause mortality. Compared with patients in the low CHA2DS2-VASc score group, those in the intermediate and high score groups had a higher risk for all-cause and CVD mortality (all-cause mortality: 50 HR 1.77, 95% CI 1.23–2.55, P=0.002 and HR 2.94, 95% CI 1.90–4.53, P<0.001, respectively; CVD mortality: HR 1.82, 95% CI 1.27–2.59, P=0.001 and HR 2.85, 95% CI 1.88–4.31, P<0.001, respectively). Conclusion. The CHA2DS2-VASc score is a valuable predictor of 3-year all-cause and CVD mortality in incident hemodialysis patients. |
|
言語 |
en |
| 出版者 |
|
|
出版者 |
Karger |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 出版タイプ |
|
|
出版タイプ |
AM |
|
出版タイプResource |
http://purl.org/coar/version/c_ab4af688f83e57aa |
| 関連情報 |
|
|
関連タイプ |
isVersionOf |
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1159/000522225 |
| 開始ページ |
|
|
開始ページ |
169 |
| 書誌情報 |
en : American Journal of Nephrology
巻 53,
号 2-3,
p. 169-175,
発行日 2022-03-08
|
| 旧ID |
54596 |
AmJNeph_53_169.pdf (2.4 MB)
